News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Suraj Samtani: Real-World Study of first Line Nivolumab plus Ipilimumab in Unresectable Pleural Mesothelioma
Photo from Suraj Samtani/X
Oct 2, 2024, 15:14

Suraj Samtani: Real-World Study of first Line Nivolumab plus Ipilimumab in Unresectable Pleural Mesothelioma

Suraj Samtani, Medical Oncologist at Harvard Medical School, shared a post on X, about recent paper published in Clinical Lung Cancer:

Efficacy of First-Line Nivolumab plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM).

Authors: Diego Enrico, Juan Elias Gomez, Danilo Aguirre, Natalia Soledad Tissera, Florencia Tsou, Carmen Pupareli, Delfina Peralta Tanco, Federico Waisberg, Andrés Rodríguez, Manglio Rizzo, Nicolás Minatta, Picon Rafael, Luis Basbus, Lorena Lupinacci, Diego Kaen, Mauro Ramos, Virginia Bluthgen, Nicolas Castagneris, María Pía Coppola, Alejandra Scocimarro, María Florencia Guerra, Aldo Perfetti, Patricio Levit, Marco Galvez-Nino, Luis Mas, Leonardo Rojas, Jairo Zuluaga, Matías Chacón, Luis Corrales, Suraj Samtani, Oscar Arrieta, Andrés Cardona, Jordi Remon, Claudio Martín.

Suraj Samtani

”Glad to share our latest article Real-World Study of 1st Line Nivolumab plus Ipilimumab in Unresectable Pleural Mesothelioma.

A Great collaboration of many great colleagues led by Diego Enrico.”

Source: Suraj Samtani/X

Aldo Perfetti Alejandra Scocimarro Andres Cardona Andrés Rodríguez cancer Carmen Pupareli Claudio Martin Clinical Lung Cancer Danilo Aguirre Delfina Peralta Tanco Diego Enrico Diego Kaen Federico Waisberg Florencia Tsou Harvard Medical School ipilimumab Jairo Zuluaga Jordi Remon Juan Elias Gomez Leonardo Rojas Lorena Lupinacci Luis Basbus Luis Corrales Luis Mas Manglio Rizzo Marco Galvez-Nino María Florencia Guerra María Pía Coppola Matías Chacón Mauro Ramos Natalia Soledad Tissera Nicolas Castagneris Nicolás Minatta nivolumab OncoDaily Oncology Oscar Arrieta Patricio Levit Picon Rafael Suraj Samtani Virginia Bluthgen
Special Coverage
Blog
Nov 21, 2024, 06:52
Sylvester’s third annual Art is Medicine exhibit's new theme is "The Bridge to Bahia"
Blog
Nov 21, 2024, 06:49
OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
Blog
Nov 21, 2024, 06:44
Hedley Lewis: Gratitude to all The Cows who participated in the Virgin Active South Africa Ride Joburg
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024
Blog
Nov 20, 2024, 20:38
Franklin Iheanacho: Changing treatment patterns for hepatocellular carcinoma
Insight
Nov 20, 2024, 20:27
HIPEC improves overall survival in recurrent epithelial ovarian cancer
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC